<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biomarkers was gradually facilitated by the adoption of proteomic strategies due to less invasiveness and higher sensitivity </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is one of the most commonly occurring <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> worldwide and its incidence has markedly increased in Korea </plain></SENT>
<SENT sid="2" pm="."><plain>While the adoption of proteomic strategies facilitated the study of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biomarkers, to date, no common agreement has been derived from proteomic investigations regarding <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>This study was designed to find molecules differentially expressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> compared to non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mucosa </plain></SENT>
<SENT sid="4" pm="."><plain>Four colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and corresponding non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue samples were analyzed to find previously unknown proteins via two-dimensional electrophoresis and MALDI-TOF/MS spectrometry </plain></SENT>
<SENT sid="5" pm="."><plain>Western blot assays and tissue microarray (<z:chebi fb="39" ids="18139,53050">TMA</z:chebi>) immunohistochemistry were performed to validate the identified proteins </plain></SENT>
<SENT sid="6" pm="."><plain>Among the twelve up-regulated and one down-regulated proteins identified, moesin, cytokeratin (KRT) 17 and carbonic anhydraseÂ I were validated by western blot analysis and/or immunohistochemistry </plain></SENT>
<SENT sid="7" pm="."><plain>On immunohistochemistry, both moesin and KRT17 demonstrated a tendency of increased expression as pT stage advanced </plain></SENT>
<SENT sid="8" pm="."><plain>Both moesin and KRT17 were not expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal epithelium </plain></SENT>
<SENT sid="9" pm="."><plain>These two proteins may play a role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> invasion and/or <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>, and could be candidate biomarkers for the diagnosis and prognosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>